BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37077070)

  • 1. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
    Gupta R; Garg N; Singh A; Jain SL
    Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
    Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
    Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
    BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
    Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
    Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
    Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PD-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
    Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
    [No Abstract]   [Full Text] [Related]  

  • 12. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
    Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
    Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
    Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
    Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.
    Morilla A; Gonzalez de Castro D; Del Giudice I; Osuji N; Else M; Morilla R; Brito Babapulle V; Rudenko H; Matutes E; Dearden C; Catovsky D; Morgan GJ
    Leuk Lymphoma; 2008 Nov; 49(11):2108-15. PubMed ID: 19021053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience.
    Sevinc M; Karabulut A; Eskazan AE; Catal Tatonyan S; Ozbek U; Soysal T
    Lab Med; 2020 May; 51(3):259-264. PubMed ID: 31589746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
    Del Principe MI; Del Poeta G; Buccisano F; Maurillo L; Venditti A; Zucchetto A; Marini R; Niscola P; Consalvo MA; Mazzone C; Ottaviani L; Panetta P; Bruno A; Bomben R; Suppo G; Degan M; Gattei V; de Fabritiis P; Cantonetti M; Lo Coco F; Del Principe D; Amadori S
    Blood; 2006 Aug; 108(3):853-61. PubMed ID: 16601244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
    Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
    Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
    Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
    Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.